Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
AIM ImmunoTech Inc.
IPO Date: August 1, 1996
Sector: Healthcare
Industry: Biotech
Market Cap: $6.52M
Activated in VL: False
Average Daily Range
Avg Daily Range: $0.11 | 3.46%
Avg Daily Range (30 D): $0.01 | 6.13%
Avg Daily Range (90 D): $0.01 | 5.34%
Institutional Daily Volume
Avg Daily Volume: .31M
Avg Daily Volume (30 D): .33M
Avg Daily Volume (90 D): .73M
Trade Size
Avg Trade Size (Sh.): 413
Avg Trade Size (Sh.) (30 D): 872
Avg Trade Size (Sh.) (90 D): 971
Institutional Trades
Total Inst.Trades: 20
Avg Inst. Trade: $1.17M
Avg Inst. Trade (30 D): $M
Avg Inst. Trade (90 D): $M
Avg Inst. Trade Volume: .41M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $.79M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 312.22K
       
News
Apr 4, 2025 @ 8:45 PM
AIM ImmunoTech Announces NYSE American Notice of D...
Source: Aim Immunotech Inc.
Dec 14, 2024 @ 9:54 PM
Kellner Group Denounces False Rumors About AIM Sho...
Source: N/A
Dec 12, 2024 @ 2:00 PM
AIM ImmunoTech Expands Patent Portfolio with New N...
Source: Aim Immunotech Inc.
Sep 27, 2024 @ 12:00 PM
AIM ImmunoTech to Participate in Virtual Investor ...
Source: Aim Immunotech Inc.
Aug 16, 2024 @ 11:00 AM
AIM ImmunoTech Reports Second Quarter 2024 Financi...
Source: Aim Immunotech Inc.
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.31 $-.1 $-.31
Diluted EPS $-.31 $-.1 $-.31
Revenue $ .17M $ .05M $ .17M
Gross Profit $ $ $
Net Income / Loss $ -17.32M $ -5.97M $ -17.32M
Operating Income / Loss $ -19.77M $ -5.86M $ -19.77M
Cost of Revenue $ $ $
Net Cash Flow $ -3.74M $ .79M $ -3.74M
PE Ratio